首页> 外文期刊>Journal of biological inorganic chemistry: JBIC: a publication of the Society of Biological Inorganic Chemistry >Metals in medicine: metal-related diseases-Synthesis, purification, and characterization of asymmetric Pt(IV) complexes that inhibit the Stat3 signal transduction pathway
【24h】

Metals in medicine: metal-related diseases-Synthesis, purification, and characterization of asymmetric Pt(IV) complexes that inhibit the Stat3 signal transduction pathway

机译:药物中的金属:与金属有关的疾病-抑制Stat3信号转导途径的不对称Pt(IV)配合物的合成,纯化和表征

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The asymmetric Pt(IV) complex, fac-[PtCl_3(NH_3)_2(NO_2)] (CPA-7, Figure 1), has been shown to control tumor cell growth by inhibiting the Stat3 signal transduction pathway [1]. Although an improved synthesis of CPA-7 was reported by Littlefield et al. [2], uncertainty as to the exact nature of the reaction product(s) and the lack of the essential details of its purification and purity warrant a reinvestigation of this system.
机译:非对称Pt(IV)复合物fac- [PtCl_3(NH_3)_2(NO_2)](CPA-7,图1)已显示可通过抑制Stat3信号转导途径来控制肿瘤细胞的生长[1]。尽管Littlefield等报道了CPA-7的合成得到改善。 [2],由于反应产物确切性质​​的不确定性以及缺乏其纯化和纯度的基本细节,因此需要对该系统进行重新研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号